Guidelines for the use of cell lines in biomedical research

R J Geraghty, Amanda Capes‐Davis, John M. Davis, +9

British Journal of Cancer

EngineeringPathologyCell-line MisidentificationCell CultureBiomedical Engineering +20

The Extracellular Matrix Protein TGFBI Induces Microtubule Stabilization and Sensitizes Ovarian Cancers to Paclitaxel

Ahmed A. Ahmed, Anthony D. Mills, Ashraf E.K. Ibrahim, +14

Cancer Cell

MedicineGynecologySensitizes Ovarian CancersMatrix BiologyCancer Biology +5

A 1 Mb minimal amplicon at 8p11–12 in breast cancer identifies new candidate oncogenes

María J. García, Jessica C. Pole, Suet‐Feung Chin, +11

Oncogene

Cancer ResearchEngineeringMedicineMolecular BiologyCancer Genomics +9

Using array-comparative genomic hybridization to define molecular portraits of primary breast cancers

Suet‐Feung Chin, Yanzhong Wang, Natalie Thorne, +15

Oncogene

Radiation OncologyPrimary Breast CancersEngineeringBreast OncologyTumor Heterogeneity +13

HES6 drives a critical <scp>AR</scp> transcriptional programme to induce castration‐resistant prostate cancer through activation of an <scp>E</scp> 2 <scp>F</scp> 1‐mediated cell cycle network

Antonio Ramos‐Montoya, Alastair Lamb, Roslin Russell, +17

EMBO Molecular Medicine

Promoter methylation correlates with reduced Smad4 expression in advanced prostate cancer

Alan Aitchison, Abhi Veerakumarasivam, Maria Vias, +4

The Prostate

Absence of p300 induces cellular phenotypic changes characteristic of epithelial to mesenchyme transition

Davia Krubasik, N. Gopalakrishna Iyer, William English, +6

British Journal of Cancer

Clonal somatic copy number altered driver events inform drug sensitivity in high-grade serous ovarian cancer

Filipe Correia Martins, Dominique‐Laurent Couturier, Inês de Santiago, +30

Nature Communications

Somatic VariantTumor HeterogeneityChromosomal InstabilityMedicineGynecology +12

Pro-neural transcription factors as cancer markers

Maria Vias, Philip East, Helen E. Scott, +5

BMC Medical Genomics

A role for neurotensin in bicalutamide resistant prostate cancer cells

Maria Vias, Glyn Burtt, Zoran Čulig, +3

The Prostate